As the Uvalde community recovers from a tragic shooting, Superior HealthPlan is developing a new community center to serve as a resource for the region. Effective September 7, 2021, the Board of Directors (the "Board") of Centene Corporation (the "Company") elected Sarah M. London as Vice Chairman of the Board of Directors of Centene Corporation and Brent D. Layton as the Company's President and Chief Operating Officer. Prior to Optum Ventures, Ms. London served as Chief Product Officer for Optum Analytics, the business unit responsible for driving strategy and commercialization of Optum's integrated data and analytics solutions into the provider, payer and life sciences markets. This Supreme Court Case Could Redefine Crime, YellowstoneBackers Wanted to Cash OutThen the Streaming Bubble Burst, How Countries Leading on Early Years of Child Care Get It Right, Female Execs Are Exhausted, Frustrated and Heading for the Exits, No Major Offer Expected on Childcare in UK Budget, Biden Gives Medal of Honor to Trailblazing Special Forces Member, Climate Change Is Launching a MutantSeed Space Race, UK Braces for Rare Weather Event That Risks Late-Winter Freeze, This Former Factory Is Now New Taipeis Edgiest Project, What Do You Want to See in a Covid Memorial? Share Your Design Ideas, New JerseysMurphy Defends $10 Billion Rainy Day Fund as States Economy Slows, This Week in Crypto: Ukraine War, Marathon Digital, FTX. David Westin speaks with top names in finance about the week's biggest issues on Wall Street. HealthCare Enterprises is a portfolio of high growth companies independent of Centene health plans, designing differentiated platform capabilities and delivering industry-leading products and . The board of Centene has picked Sarah London an executive with roots in venture capital and talent. Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox. You may also find the annual proxy statement by going directly to the company's website. Ms. London has spent her career at the forefront of innovation in healthcare. Centenes large size and central role in behavioral care management mean that it could affect what retirement planning clients Medicare plans look like, what the plans will cost, and how both working-age and older clients plans cover mental health care, behavioral health care and other types of care. In 2010, she helped start a health care cost and quality data business for Accretive Health, a medical billing and debt collection company. London is also dedicated to prioritizing wellness for employees, including through enhanced caregiver benefits. Before joining Centene in 2020, Ms. London was a Partner at Optum Ventures, the venture capital arm of UnitedHealth Group. Mar. Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. I have been consistently impressed by Sarahs passion to serve our members, who are often the most vulnerable amongst us.. Before joining Centene in 2020, Ms. London was a Partner at Optum Ventures, the venture capital arm of UnitedHealth Group. Mr. Neidorff remains on a previously announced medical leave of absence from his position on the Board of the Company. Centene Corporation, (d) Election of Sarah London as a Member of the Board, ITEM 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, https://investors.centene.com/. Ms. London received an M.B.A. with High Honors from the University of Chicago Booth School of Business and a B.A. ESG: The Implementation Imperative Summit. I write about healthcare business and policy. This list of important factors is not intended to be exhaustive. The salaries that employees earn in Centene can be influenced by the department or organization function that they work in. Net income dropped 26% to $1.3 billion. We have a unique opportunity to empower our members, providers, and their communities in this transformation.. Sarah London is the Chief Executive Officer of Centene Corporation, a diversified healthcare enterprise providing a portfolio of government-sponsored healthcare programs focusing on under-insured and uninsured individuals to more than 26 million Americans. Gender Female. Get alerted any time new stories match your search criteria. Glassdoor gives you an inside look at what it's like to work at Centene, including salaries, reviews, office photos, and more. This report is not for commercial use. Magna Cum Laude in History & Literature from Harvard College, where she played Division I tennis. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings. Michael built one of the great success stories in American business, and his commitment to providing affordable, high-quality healthcare to our fellow citizens will remain a bedrock of this Company going forward," said Ms. London. Her focus has been advancing integrated, value-based care models through the development and application of data-driven insights and technology. In the biggest economic-development deal in state history, the CEO of health-insurance giant Centene said Wednesday that it will build an East Coast regional headquarters and technology hub on an 80-acre site in the University City area a massive project that he said could . Centene has promoted Sarah London, the health insurance companys current board vice chair, to the job as Chief Executive Officer, succeeding the retiring Michael Neidorff, the company said Tuesday afternoon. Sarah London received her BA in Biology and Psychology from Middlebury College and her PhD in Neuroscience from UCLA. ", Drew Asher, Centene's Chief Financial Officer, said, "Sarah brings a modern vision to the helm of one of this country's most important healthcare companies. "I also want to thank Michael Neidorff, Centene's visionary leader for more than 25 years. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions. Sarah M. London. From September 2011 to June 2016, he served as the Company's Senior Vice President, Business Development. All proxy statements are public filings made available to the general public by the SEC. Cigna fell less than 0.3% to close at $234.02, giving. Brent Layton, President and Chief Operating Officer of Centene, stated, "Sarah brings a tremendous skillset to the leadership of Centene Corporation, and I'm excited to partner closely with her as Centene begins our journey into the next era of our history. . Centene elevated to the CEO job Sarah London, the company's vice chairman who has held technology [+] and strategy roles with the health insurer, the company said March 22, 2022. "Sarah has infused an innovative mindset across the enterprise in her relentless effort to improve Centene's capabilities to provide the highest quality of care for our members. Since then, the company has become a major force in the commercial health insurance market by acquiring Health Net, a California health insurer; WellCare Health Plans, a big Medicare plans issuer; and Magellan Health, a behavioral health, specialty care and pharmacy benefits manager. Sarah London. President. Centene Corporation's highest paid executives include: Jesse Hunter $4,442,868 and Keith Williamson $3,049,469. U.S. health insurer Centene Corp on Tuesday named Vice Chairman Sarah London as its new chief executive officer, replacing Michael Neidorff, who is on medical leave. Big Jumps In Diversity Fuel Surge In U.S. Tennis Participation Since 2020, Walgreens-Backed VillageMD Buys 30-Location Physician Group In Connecticut, Banning Abortion Pill Mifepristone Would Set A Dangerous Precedent For The Politicization Of Public Health, Ukraine Wars Toll Of Death, Destruction, Displacement, And Trauma: Fresh Evidence Of Systematic Planning Of Torture Leaves Behind An Indelible Mark, Walmart To Double Health Clinic Footprint As Amazon And Rivals Buy Doctor Offices, Covid-19s Enormous Death Toll: Worldwide Life Expectancy Has Experienced A Steep Decline, Questions Scientists Should Now Explore With Respect To Covid-19, Sustainable Development A Smart Solution for Africa and the Middle East, And less than a month ago, Centene said Neidorff. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to:our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; the risk that the election of new directors, changes in senior management and inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively;uncertainty as to the expected financial performance of the combined company following the recent completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; the risk that unexpected costs will be incurred in connection with the integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected, or similar risks from other acquisitions we may announce or complete from time to time; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we have recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; timing and extent of benefits from strategic value creation initiatives, including the possibility that these initiatives will not be successful, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully;restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission.